Blood Coagulation Tests
6
0
0
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
16.7%
1 terminated out of 6 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Evaluation of the Accuracy of the Hemochron Signature Elite Point of Care Device Compared With Laboratory Assay
Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation
Efficacy of a Didactic Intervention in Anticoagulated Patients (TAOPE Study)
Evaluation of the Interference of Antithrombotic Agents With Laboratory Monitoring of Heparin Therapy
Non Invasive Measurement of Coagulation in Term and Preterm Neonates
A Prospective Pharmacodynamic Study of Dabigatran